novo nordisk mash - Search News

Order byBest matchMost fresh

News

Novo Nordisk, MASH and Wegovy

· 8h · on MSN

Novo Nordisk's Weight-Loss Drug Wegovy Approved to Treat Liver Disease

Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a serious disease of the liver.Wegovy can be used for patients suffering from noncirrhotic metabolic dysfunction-associated steatohepatitis,

Continue reading

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

Fierce Pharma · 7h

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

2m

Should You Buy the Pop in Novo Nordisk Stock?

Novo Nordisk stock rallies as the Danish pharma giant makes two big announcements. TD Cowen analysts recommend buying NVO ...

3h

Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

4hon MSN

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

4don MSN

Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forces

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

4d

The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results